michigan semaglutide diarrhea class action FDA warns Ozempic and Wegovy maker over unreported GLP-1 side effects Ozempic Lawsuit – July 2026
Description
Each tablet contains an absorption enhancer called SNAC (salcaprozate sodium)
This risk is higher in patients taking Wegovy alongside insulin or sulfonylureas, and these patients may need glucose monitoring if sleep disturbances occur

Semaglutide sodium/ acetate compounding (The FDA version approved version is a semaglutide base form, not a salt form)

The main novelty of this drug is that it demonstrated in studies the most significant weight reduction among the drugs: 21 to 22.5% weight loss at its highest dose

Liu H.-M
